solid tumors

0:01:16

The future of cellular therapies for solid tumors

0:02:16

Smart Cell Therapies for Solid Cancers

0:00:39

Next generation CAR T-cell therapies for solid tumors

0:36:18

Cell Therapy in the Treatment of Solid Tumors

0:01:31

Challenges of treating solid tumors

0:01:00

Barriers to using CAR T-cells in solid tumors and strategies to overcome them

0:01:41

CAR T-cell Therapy for Solid Tumors | Stanford Cancer Institute

0:02:40

Immunotherapy in common solid tumors: an overview

0:05:37

Revolutionizing Cancer Treatment

0:14:16

What is the latest for immunotherapy for solid tumors? Dr. Randy Sweis, UChicago, Medical Oncologist

0:01:29

Developments for TILs and TCR modified cell therapy in solid tumors

0:01:41

Paediatric Solid Tumors: Diagnosis & Treatment

0:02:45

Remaining challenges in treating solid tumors with CAR-Treg therapy

0:04:44

Highlights on CAR T cells in advanced solid tumours @AACR 2022

0:01:16

Challenges of CAR T-cells in solid tumors

0:00:42

Treating HER2-positive solid tumors with TAC T-cell therapy

1:05:11

Combinatorial Immunotherapy Approaches for Patients with Advanced Solid Tumors

0:04:05

Enhancing CAR-T cell efficacy in solid tumors

0:01:45

The rationale behind the MIF-targeting antibody ON203 for solid tumors

0:26:33

HOT TOPICS | CAR-T | Solid Tumors Success | When?

0:22:19

Day 1 | Cellular Therapy for Solid Tumors - Brian Van Tine, MD, PhD – Washington University

0:00:57

ON203: the anti-oxMIF antibody targeting solid tumors

0:01:58

TAC T-cell development in solid tumors

0:01:16

MEDI1191 with durvalumab in advanced solid tumors